| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
AQP5
|
aquaporin 5
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
AURKA
|
aurora kinase A
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CD27
|
CD27 molecule
|
|
CD33
|
CD33 molecule
|
|
CD82
|
CD82 molecule
|
|
CDH13
|
cadherin 13
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTSG
|
cathepsin G
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DCC
|
DCC netrin 1 receptor
|
|
DUSP7
|
dual specificity phosphatase 7
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EN2
|
engrailed homeobox 2
|
|
ETV6
|
ets variant 6
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FN1
|
fibronectin 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXO3
|
forkhead box O3
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
H2AFX
|
H2A histone family, member X
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HOXA9
|
homeobox A9
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNA1
|
interferon, alpha 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL1B
|
interleukin 1, beta
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL6
|
interleukin 6
|
|
JAK2
|
Janus kinase 2
|
|
JUNB
|
jun B proto-oncogene
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYZ
|
lysozyme
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR181A1HG
|
MIR181A1 host gene
|
|
MIR21
|
microRNA 21
|
|
MIR328
|
microRNA 328
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP98
|
nucleoporin 98kDa
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PDCD5
|
programmed cell death 5
|
|
PHF6
|
PHD finger protein 6
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PRDM16
|
PR domain containing 16
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RBM15
|
RNA binding motif protein 15
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPHK1
|
sphingosine kinase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TP53
|
tumor protein p53
|
|
UHMK1
|
U2AF homology motif (UHM) kinase 1
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
WT1
|
Wilms tumor 1
|
